Increases seen for all race and ethnic groups, with slight increase in disparities between groups

Prevalence estimated to be almost 15 percent; risk higher for older adults and women and lower with completion of primary vaccination series before infection

No improvement seen in number of days alive and out of the hospital at 90 days for haloperidol versus placebo

Estimated change from baseline in the PHQ-9 score increased with increasing work hours

Compared with matched controls without dementia, improvement, recovery less likely for people living with dementia